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Background: A large number of Asian population studies examined the difference between the 6th and the 7th
tumor, node, metastasis (TNM) while it is still poorly validated among Caucasian populations. This is a retrospective
study aimed at investigating the efficacy of the 7th edition American Joint Committee on Cancer (AJCC)/Union for
International Cancer Control (UICC) staging system for gastric cancer focusing on the “N” parameter-related survival
for prognostic assessment in gastric cancer patients of a single Western high-volume institution.
Methods: From January 2002 to December 2009, the data of 274 patients with gastric cancer who underwent
gastric surgery at the 8th General and Gastrointestinal Surgical Centre of the Second University of Naples were
analyzed retrospectively. We collected data for patient demographics, tumor characteristics, surgical characteristics,
and TNM stage. Particularly, the nodal status, with the number of dissected nodes and metastatic nodes, was
reviewed from the pathology records. The same patient dataset was used to stage patients according to both the
6th and 7th edition criteria.
Results: Age at surgery, tumor location, histological grade, Lauren’s classification subtypes, and 6th and 7th AJCC/
UICC N categories were found to have statistically significant associations with overall survival on univariate analysis.
In the 6th edition staging system, the Kaplan–Meier plot did not show significant overlapped survival curves:
significant differences were found between N0 and N1, P < .001; N1 and N2, P = .04; and N2 and N3, P < .001. On
the contrary, in the 7th edition, among all five substages, there were similar survival curves between N categories 2
and 3a (P = .98) with a statistically significant discriminatory ability only between N1 versus N3b and N2 versus N3b
(P = .02 and .04, respectively).
Conclusions: Based on analysis, we found that several clinicopathological variables, especially histological grade
and Lauren’s classification, were significant prognostic factors in our database. The 6th and 7th AJCC/UICC N
classifications represent significantly independent prognostic factors, and the 6th AJCC/UICC N classification seems
to be superior to the 7th AJCC/UICC N classification in terms of uniformity, differentiation, and monotonicity of
gradients.
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Gastric cancer is one of the most common malignant tu-
mors in the world and the second leading cause of cancer-
related death worldwide [1–5]. Although considerable pro-
gress has been made in the early gastric cancer diagnosis,
so far, the prognosis of this tumor remains poor [6, 7].
Accurate categorization of the tumor stage, including the
invasive depth and lymph node status, is crucial for prog-
nostic assessment and decision-making of the stage-specific
therapeutic strategy [8]. The American Joint Committee on
Cancer (AJCC)/Union for International Cancer Control
(UICC) tumor, node, metastasis (TNM) staging system has
been used widely for clinical practice and research in deter-
mining tumor stage for gastric cancers, representing the
most important independent prognostic factor [9]. Several
versions of this classification system have been used over
the past 30 years [10, 11], and in 2010, the 7th edition of
the AJCC/UICC gastric cancer staging manual was intro-
duced, resulting in several changes from the 6th edition,
particularly as regards the N categories [12]. According to
the new TNM edition, N categories were so redefined in
order to improve their reproducibility and prognostic valid-
ity: the previous N1 category (1–6 involved regional lymph
nodes) is amended into a new N1 category (1–2 involved
regional lymph nodes) and N2 category (3–6 involved re-
gional lymph nodes), whereas the previous category N2
(7–15 involved regional lymph nodes) and the N3 category
(>15 involved regional lymph nodes) are combined into the
new N3 categories (N3a: 7–15 involved regional lymph
nodes, and N3b: ≥16 involved regional lymph nodes)
[2, 11]. In the medical literature, there are a large number
of Asian population studies that examine the difference be-
tween the 6th and the 7th TNM [2, 11, 13–15]; however,
gastric cancer in Western countries represents a different
disease considering the pattern of presentation and patho-
physiology [16–18]. Indeed, studies aimed at validating the
new staging criteria focusing on the N category in the Ital-
ian population are poor [19]. Thus, the prognostic capabil-
ity of this new classification in the Western remains
ambiguous. In light of such evidences, we performed a
retrospective study so-called NodUs study (Nodal statUs)
to evaluate the efficacy and validity of the 7th edition
AJCC/UICC “N” category for prognostic assessment and to
compare the 6th and 7th editions of the AJCC/UICC “N”
staging system focusing on the “N” parameter in a cohort
of patients who underwent surgical therapy for gastric can-
cer from a single Western high-volume institution, provid-
ing reference for revision of a future edition of the AJCC/
UICC for gastric cancer staging.
Methods
From January 2002 to December 2009, the data of 329
patients with gastric adenocarcinoma (ICD-O code
8140/3 according to the World Health Organizationclassification of tumors of the digestive system) [20] con-
firmed by histopathology who underwent gastric surgery
at the 8th General and Gastrointestinal Surgical Centre
of the Second University of Naples were analyzed retro-
spectively. Exclusion criteria were previous history of
surgery for gastric cancer, gastric stump cancer, meta-
static disease, non-curative resection (R1 or R2 resec-
tion), lymphadenectomy different from D2, inadequate
lymph node dissection (<15 lymph nodes retrieved), pre-
operative radiotherapy, and/or chemotherapy. More spe-
cifically, in D1 dissections, only the perigastric nodes
directly attached along the lesser curvature and greater
curvatures of the stomach are removed (stations 1–6:
right and left pericardial, lesser curvature, greater curva-
ture, supra, and infrapyloric). D2 dissections add the re-
moval of nodes along the left gastric artery (station 7),
common hepatic artery (antero-superior group, station
8a), celiac trunk (station 9), splenic hilum and splenic
artery (station 10 and 11), and hepatoduodenal ligament
(along the proper hepatic artery, station 12a) [21].
After applying the exclusion criteria, a total of 274 pa-
tients were enrolled in this study.
All patients underwent standardized total or partial
gastrectomy (depending on the distance between the
cardia and the tumor) by experienced surgeons, with
spleen-preserving modified radical D2 lymphadenectomy
according to the Japanese Classification of Gastric
Carcinoma [21]. However, splenectomy was necessarily
performed in a total of 19 patients (6.9 %) to ensure
complete dissection of the splenic hilar lymph nodes in
very difficult dissection cases. The surgical procedure of
reconstruction was chosen according to the surgeon’s
preference. We collected data for patient demographics,
tumor characteristics, surgical characteristics, and TNM
stage. Particularly, the nodal status, with the number of
dissected and metastatic nodes, was reviewed from the
pathology records. The same patient dataset was used to
stage patients according to both the 6th and 7th edition
criteria.
Surviving patients were followed at regular intervals at
the outpatient clinic until 5 years after surgery. Out-
patient clinic visits included history taking and physical
examination. No routine imaging was performed. Over-
all survival, used as a prognostic parameter, was defined
as the time between the date of operation and the date
of death. Surviving patients were censored on the day of
last follow-up. The last follow-up checkpoint was July
2014.
Ethics, consent, and permissions
The study was approved by the ethics committee of the
Second University of Naples and conducted according to
the ethical standards of the Helsinki Declaration. All pa-
tients gave informed consent to participate in this study.
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Consents to publish have been obtained from the partic-
ipants (or legal parent when appropriate) to report indi-
vidual patient data.
Statistical analysis
The observed data were normally distributed. Overall
survival (OS) was calculated using the Kaplan–Meier
method, and the log-rank test was employed to deter-
mine the significance.
Factors that were deemed of potential importance on
univariate analysis, considering a P value of less than .05
as a statistically significant result, were included in
multivariate analyses. Multivariate analysis was per-
formed by the Cox proportional hazard model using the
forward logistic regression stepwise procedure for vari-
able selection. To measure homogeneity of the direct
comparison of the two different edition stage systems,
the likelihood ratio χ2 test related to the Cox regression
model was used. The discriminatory ability and mono-
tonicity of gradient assessments were measured with the
linear trend χ2 test of survival curves according to the N
classification of the 6th and 7th editions. The Akaike in-
formation criterion (AIC) was applied into the Cox pro-
portional hazard regression model to correct for the
potential bias in comparing prognostic systems with dif-
ferent numbers of stages. AIC was defined as follows:
AIC = −2 log maximum likelihood + 2 × (the number of
parameters in the model). A smaller AIC value indicated
a better model for predicting outcome [22, 23]. Hazard
ratios (HR) and 95 % confidence intervals (95 % CI)
were generated. A statistical data analysis was performed
using SPSS 20.0 software (SPSS Inc., Chicago, IL), and a
P value of less than .05 was considered to be statistically
significant.
Results
A consecutive series of 329 patients with diagnosis of
gastric adenocarcinoma was analyzed retrospectively. In
total, 20 patients were excluded because they had re-
ceived neoadjuvant chemotherapy, 8 patients were ex-
cluded because of a non-curative (R1) resection, and 17
patients were excluded because of inadequate lymph
node dissection and lymphadenectomy different from
D2 (D1 lymphadenectomy). Ten patients had a meta-
static disease and were also excluded from the current
analysis. This resulted in a final study population of 274
patients. Mean follow-up was 53 months (median
39 months). The overall 5-year survival rate was 52.8 %.
Age at surgery, tumor location, histological grade, Lau-
ren’s classification subtypes, and 6th and 7th AJCC/
UICC N parameters were found to have statistically sig-
nificant associations with overall survival on univariate
analysis. Patient characteristics and the effect of clinicalfeatures on survival are summarized in Table 1. No
lymph node metastasis was found in 66 patients
(23.9 %). The number of metastatic nodes was 1–6 (N1)
in 103 patients (37.6 %), 7–15 (N2) in 61 patients
(22.2 %), and more than 15 (N3) in 44 patients (16.2 %)
according to the TNM 6th criteria. The number of meta-
static nodes was 1–2 (N1) in 44 patients (16.2 %), 3–6
(N2) in 71 patients (26.1 %), 7–15 (N3a) in 60 patients
(21.8 %), and more than 15 (N3b) in 33 patients (12 %)
according to the new TNM 7th criteria. The total num-
ber of dissected lymph nodes was 7267, with an average
of 26.5 ± 14.8 (mean ± SD) dissected nodes per case
(median 24.0, range 0–87). The mean number of meta-
static nodes was 6.5 ± 8.2 (median 4, range 0–55) in the
overall series and 8.5 ± 8.4 (median 6, range 1–55) in
lymph node-positive patients (data not shown). Figure 1
shows the 5-year survival rates for patients with N0
(66.0 %), N1 (52.1 %), N2 (50.0 %), and N3 (31.0 %) dis-
ease (P < .001) according to the AJCC/UICC 6th edition
system. Also shown in Fig. 2 are the 5-year survival rates
according to the AJCC/UICC 7th edition: N0 (66.0 %),
N1 (66.7 %), N2 (48.1 %), N3a (51.2 %), and N3b
(20.8 %) (P < .001). Indeed, in the 6th edition staging sys-
tem, the Kaplan–Meier plot did not show significant
overlapped survival curves: significant differences were
found between N0 and N1, P < .001; N1 and N2, P = .04;
and N2 and N3, P < .001. On the contrary, in the 7th
edition, among all five substages, there were similar sur-
vival curves between N categories 2 and 3a (P = .98) with
statistically significant discriminatory ability only be-
tween N1 versus N3b and N2 versus N3b (P < .001 and
.04, respectively).
All six variables that resulted in statistical significance as-
sociated with overall survival on univariate analysis were
included in a multivariate Cox proportional hazard model
with forward logistic regression stepwise procedure to ad-
just for the effects of covariates. Therefore, two separate
multivariate models, one with the 6th and the other with
the 7th AJCC/UICC N classification, were run to avoid col-
linearity problems. In these models, we demonstrated that
histological grade, the 6th AJCC N parameters, and the 7th
AJCC/UICC N parameters were independent factors of
prognosis of gastric cancer (Table 2). After that, a Cox re-
gression model including both the 6th and 7th edition sta-
ging systems focusing on the “N” parameter showed that
the 7th edition no longer significantly predicted survival,
whereas the 6th edition remained a significant stratifier of
prognosis (data not shown). Finally, the performance of the
6th and 7th edition N classification systems was quantified
by the likelihood ratio chi-square, linear trend χ2 test, and
AIC. Predictive ability was best for the 6th AJCC/UICC N
classification system (highest likelihood ratio χ2) as well as
the discriminatory ability and monotonicity of gradients
(higher linear trend χ2 score). Furthermore, the AIC value
Table 1 Univariate survival analysis of clinicopathological
variables in 274 gastric cancer patients
N (%) 5-year
survival rate (%)
Log-rank
χ2 value
P value
Gender 1.987 0.159
Female 95 (34.7) 50.6
Male 179 (65.3) 42.7
Age at surgery (years) 3.247 0.047
≤40 14 (5.1) 80.0
41–60 90 (32.8) 41.9
>61 170 (62.1) 44.5
Tumor location 4.786 0.025
Upper 77 (28.1) 43.1
Upper-middle 34 (12.4) 38.7
Middle 72 (26.3) 42.9
Middle-lower 29 (10.6) 41.7
Lower 62 (22.6) 56.4
Histological grade 6.788 0.009
Well + moderately
differentiated
129 (47.1) 51.7
Poorly differentiated
+ signet ring cell
145 (52.9) 38.7
Lauren’s classification 9.772 0.002
Intestinal type 104 (38.0) 54.7
Diffuse type 170 (62.0) 39.7
Type of gastrectomy 0.656 0.199
Subtotal 40 (14.6) 47.1
Total 234 (85.4) 45.2
The 6th N stage (AJCC) 17.013 0.002
N0 66 (23.9) 66.0
N1 103 (37.6) 52.1
N2 61 (22.2) 50.0
N3 44 (16.2) 31.0
The 7th N stage (AJCC) 29.483 0.0003
N0 66 (23.9) 66.0
N1 44 (16.2) 66.7
N2 71 (26.1) 48.1
N3a 60 (21.8) 51.2
N3b 33 (12.0) 20.8
AJCC American Joint Committee on Cancer, N node
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staging system, indicating that it has a better prognostic
stratification (Table 2).
Discussion
The major finding of our investigation on 274 gastric
cancer Italian patients who underwent primary surgicalresection is that the 6th and 7th AJCC/UICC N classifi-
cations represent significantly independent prognostic
factors, and the 6th AJCC/UICC N classification seems
to be superior to the 7th AJCC/UICC N classification in
terms of uniformity, differentiation, and monotonicity of
gradients. Nowadays, the prognosis for gastric cancer
patients remains poor, and the TNM stage system repre-
sents a prognostic factor that can effectively provide the
means for appropriate treatment and predict the prog-
nosis [23, 24]. Especially the extent of lymph node me-
tastasis is proved to be the most important independent
prognostic factor [25, 26]. The introduction of the new
7th AJCC/UICC TNM edition has brought several
changes for gastric cancer classification, and 4 years
later, there are still some debates about its prognostic
power. Furthermore, in the literature are reported scien-
tific contributions with controversial results about com-
parison between the 6th and the 7th AJCC/UICC N
classification systems. Wang et al. [1] reported a better
prognostic stratification of the latest TNM edition in
1503 gastric cancer patients who underwent primary
surgical resection with an average per case of dissected
lymph nodes less than 15, considering avoidable N3 sub-
stratification in N3a and N3b. Similarly, Deng et al. [27],
Chae et al. [28], and Fang et al. [15] showed a more de-
tailed classification of different prognostic groups with a
high homogeneity rate in each TNM stage in R0-
selected patients with more than 16 retrieved lymph
nodes per case [29], assessing prognostic superiority for
the 7th than for the 6th AJCC/UICC N classification
system. From the Western point of view, McGhan et al.
[25] evidenced a better survival discrimination and risk
stratification of the 7th AJCC/UICC staging criteria in a
retrospective review of 13,547 American gastric cancer
patients. In order to evaluate the efficacy and validity of
the 7th edition AJCC/UICC “N” classification system for
prognostic assessment and to compare the 6th and 7th
editions of the AJCC/UICC “N” classification system, we
analyzed 274 patients who underwent curative surgery
by experienced surgeons in this “NodUs” retrospective
study.
Our data analysis, different from Asian surgeons’ re-
sults, showed that survivals according to the 6th AJCC/
UICC N classification were more equally distributed
than survivals according to the new AJCC/UICC classifi-
cation. Moreover, in univariate analysis, significant prog-
nostic factors were the age at surgery, tumor location,
histological grade, Lauren’s classification, the 6th AJCC/
UICC N category, and the 7th AJCC/UICC N category.
However, the two multivariate analysis models showed
that histological grade, the 6th AJCC/UICC N classifica-
tion, and the 7th AJCC/UICC N classification were
independent factors of prognosis of gastric cancer. Fur-
thermore, when a Cox regression model including both
Fig. 1 Survival curves for 274 patients according to the 6th AJCC N classification
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“N” parameter was run, only the 6th AJCC/UICC N
classification remained a significant stratifier of progno-
sis with high prediction as well as the discriminatory
ability and monotonicity of gradients. Similarly, some
Eastern surgeons did not report the 7th AJCC/UICC NFig. 2 Survival curves for 274 patients according to the 7th AJCC N classificclassification as having a more effective prognostic power
compared to the 6th edition [2, 4, 30]. Likewise, Rausei
et al. [31] in a retrospective unique Italian “real-world”
comparative study on 224 non-metastatic gastric cancer
patients who underwent surgery with curative intent and
limited lymphadenectomy (D1 lymphadenectomy) did notation
Table 2 Two multivariate analysis models of overall survival in gastric cancer patients
Variables Hazard ratio 95 % CI P value
(a) 6th AJCC N staging system (−2 log likelihood: 1548.021; linear trend χ2: 1501.231; AIC value: 2591.3)
Age at surgery 1.025 0.748–1.598 0.652
Tumor location 0.984 0.548–1.746 0.985
Histological grade 0.745 0.624–1.348 0.015
Lauren’s classification 0.864 0.521–1.681 0.312
The 6th N stage (AJCC) 1.256 0.894–1.612 0.007
(b) 7th AJCC N staging system (−2 log likelihood: 1541.013; linear trend χ2: 1498.564; AIC value: 2601.4)
Age at surgery 1.101 0.809–1.494 0.884
Tumor location 1.003 0.756–1.319 0.731
Histological grade 0.639 0.517–1.214 0.021
Lauren’s classification 0.931 0.611–1.306 0.424
The 7th N stage (AJCC) 1.481 1.112–2.031 0.011
95 % CI 95 % confidence interval, AJCC American Joint Committee on Cancer, AIC Akaike information criterion, N node
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TNM edition with respect to the N parameter in compari-
son to the 6th edition. As stated by Bickenbach et al. [16]
and McGhan et al. [25], gastric cancer in Western coun-
tries represents a different disease as regards the pattern
of presentation and pathophysiology making the classifica-
tion according to the new 7th AJCC/UICC N classification
system not better than the old 6th TNM for the prognos-
tic stratification of staging in gastric cancer. Further na-
tionwide studies with larger numbers of patients are
necessary to evaluate the validity and effectiveness of the
new classification from various angles.
Conclusions
Although our sample population comes from a single in-
stitution experience and is relatively small compared
with the worldwide gastric cancer collaboration data-
base, the surgical procedures, pathologic examinations,
and patient follow-up were highly uniform throughout
the entire study period. Moreover, it represents an ori-
ginal retrospective study on the Italian population. In
our analysis, we found that several clinicopathological
variables, especially histological grade and Lauren’s clas-
sification, were significant prognostic factors in our data-
base worthy of further research. Overall, the 6th and 7th
AJCC/UICC N classifications represent significantly in-
dependent prognostic factors, and the 6th AJCC/UICC
N classification seems to be superior to the 7th AJCC/
UICC N classification in terms of homogeneity, discrim-
inatory ability, and monotonicity of gradients, providing
reference for revision of a future edition of the AJCC/
UICC for gastric cancer staging.
Abbreviation
AIC: Akaike information criterion; AJCC: American Joint Committee on
Cancer; CI: confidence interval; HR: hazard ratio; OS: overall survival;
TNM: tumor, node, metastasis.Competing interests
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